Pulmonary Arterial Hypertension: Combination Therapy in Practice

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

(2017) David Kylhammar et al.   EUROPEAN HEART JOURNAL

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

(2017) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

(2017) Athénaïs Boucly et al.   EUROPEAN RESPIRATORY JOURNAL

Risk Factors for Nonadherence to Antihypertensive TreatmentNovelty and Significance

(2017) Pankaj Gupta et al.   HYPERTENSION

Clinical Considerations for Use of Initial Combination Therapy in Type 2 Diabetes

(2016) Avivit Cahn et al.   DIABETES CARE

Initial dual oral combination therapy in pulmonary arterial hypertension

(2016) Olivier Sitbon et al.   EUROPEAN RESPIRATORY JOURNAL

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN RESPIRATORY JOURNAL

Selexipag for the Treatment of Pulmonary Arterial Hypertension

(2015) Olivier Sitbon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

From Short-Term Benefits to Long-Term Outcomes: The Evolution of Clinical Trials in Pulmonary Arterial Hypertension

(2014) Murali M. Chakinala et al.   Pulmonary Circulation

Combination Therapy in Pulmonary Arterial Hypertension

(2013) Richard N. Channick   AMERICAN JOURNAL OF CARDIOLOGY

Pulmonary Arterial Hypertension

(2013) Michael D. McGoon et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

(2013) Tomás Pulido et al.   NEW ENGLAND JOURNAL OF MEDICINE

Riociguat for the Treatment of Pulmonary Arterial Hypertension

(2013) Hossein-Ardeschir Ghofrani et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changing Demographics, Epidemiology, and Survival of Incident Pulmonary Arterial Hypertension

(2012) Yi Ling et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

(2012) Marius M. Hoeper et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Pleiotropic Effects of Phosphodiesterase 5 Inhibitors on Function and Safety in Patients With Cardiovascular Disease and Hypertension

(2012) Steven G. Chrysant et al.   Journal of Clinical Hypertension

Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States

(2012) Paul E. Sax et al.   PLoS One

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies

(2011) Jérôme Le Pavec et al.   ARTHRITIS AND RHEUMATISM

Clinical Pharmacokinetics and Drug-Drug Interactions of Endothelin Receptor Antagonists in Pulmonary Arterial Hypertension

(2011) Jürgen Venitz et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension

(2010) Vallerie V. McLaughlin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   CHEST